M&A Update – Oct 14

– LBPH to be acquired by H. Lundbeck A/S for $60.00 cash per share, 54.2% premium, $2.5 billion
– VNDA / Cycle Pharmaceuticals reaffirmed unsolicited proposal at $8.00 cash per share
– SQSP / Permira tender successful, filed delisting notice, closing Oct 17
– ARCH / CEIX cleared HSR
– ESGR / Sixth Street / Liberty Strategic Capital / J.C. Flowers filed DEFM14a, vote Nov 6, closing mid 2025
– GIVX.to / FOUR filed management information circular, vote Nov 1, closing in early Nov 2024
– BATL / Fury Resources filed PRER14a, no meeting date set, closing Q4 2024
– EDR / Silver Lake filed PRER14c, no mailing date set, closing Q1 2025
– MR-U go-shop ends
– TSX closed
– EDGAR closed